
Verum Strains
Probiotics are defined as living microorganisms which upon digestion in certain numbers, exert health benefits beyond basic nutrition. The dairy products VERUM HÄLSOFIL and VERUM® HÄLSOYOGHURT are examples of very succesful probiotics on the Swedish market. They contain the patented strains Lactococcus lactis L1A and Lactobacillus rhamnosus LB21, which have been isolated, studied and clinically documented in close collaboration between researchers at Umeå University and the dairy company Norrmejerier in Umeå.
LACTOCOCCUS LACTIS L1A
The probiotic strain Lactococcus lactis L1A originates from a traditional milk
fermentation culture. The specific strain was isolated from one out of several
hundreds of wild starter cultures that were collected from diffirent farms in
the North of Sweden during the 1970's. In 1993 Lactococcus lactis L1A was patented
because of it's unique in vitro inhibitory effect on potentially pathogenic
enteric bacteria like Salmonella sp. and Shigella sp. TABLE
1 .
To be able to positively affect the gastrointestinal ecosystem, the probiotic strain has to survive the passage through the harsh enviroment in the upper part of the gut. When 13 healthy individuals consumed Lactococcus lactis L1A for three consecutive days, the strains could be recovered from stool samples in 12 out of 13 tested volunteers.
Another similar clinical study on 21 healthy volunteers showed that Lactococcus
lactis L1A was present in faecal samples up to 15 days after the final dose
of peroral bacteria, with a mean duration of eight days. FIGURE
1 .
LACTOBACILLUS RHAMNOSUS LB21
The probiotic strain Lactobacillus rhamnosus LB21 is of human origin. In 1993
it was isolated from the intestine of a 5-day old child. During the inital
in vitro tests, Lactobacillus rhamnosus LB21 showed to be very good growth
inhibitor of Gram-negative bacteria such as Salmonella sp. and Escherichia
sp.
Furthermore, Lactobacillus rhamnosus LB21 inhibits the growth of Helicobacter
pylorii in vitro.
Lactobacillus rhamnosus LB21, like Lactococcus lactis L1A, survives the passage
through the gastrointestinal tract very well. When 13 healthy volunteers had
a salline solution of the specific probiotic LB21 strain every day for five
days, Lactobacillus rhamnosus LB21 could be isolated from faecal samples up
to twelve days after the intake of the LB21 strain had stopped. FIGURE
2 .



